跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUPRIPEN 250 CAPSULE 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
CUPRIPEN 250 CAPSULE 250 MG
Approved
THERAPEUTIC
CUPRIPEN 250 CAPSULE 250 MG
LABORATORIOS RUBIO SA (SPAIN)
🇸🇬 Health Sciences Authority
Approval Date
May 17, 1995
Approval ID
5885dd6e811c9ec1
Company
LABORATORIOS RUBIO SA (SPAIN)
Type
Therapeutic
Approval Details
Approval Id
5885dd6e811c9ec1
Drug Name
CUPRIPEN 250 CAPSULE 250 MG
Product Name
CUPRIPEN 250 CAPSULE 250 MG
Approval Number
SIN08173P
Approval Date
1995-05-17
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
M01CC01
Atc Item Name
penicillamine
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
D-PENICILLAMINE
250 mg
D-PENICILLAMINE
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 17, 1995
Approval ID
5885dd6e811c9ec1
Type
Therapeutic
Back to HSA Approvals